Clinical trial · Interventional
Lateral Prostate Capsule Sparing Versus Nerve Sparing Robot-assisted Radical Cystectomy-orthotopic Ileal Neobladder for Bladder Cancer in the Male
NCT04966949CI-TRIAL-00052745unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To compare the perioperative, functional, and oncologic outcomes between nerve sparing and lateral prostate capsule sparing robot-assisted radical cystectomy with orthotopic ileal neobladder in male patients with bladder cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| lateral prostate capsule sparing or neurovascular bundles sparing | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- lateral prostate capsule sparing group
- description
- Patients will be preverved the lateral prostate capsule during the resection of bladder and prostate of the operation.
- interventionNames
- Procedure: lateral prostate capsule sparing or neurovascular bundles sparing
- type
- ACTIVE_COMPARATOR
- label
- nerve sparing group
- description
- Patients will be preverved the neurovascular bundles during the resection of bladder and prostate of the operation.
- interventionNames
- Procedure: lateral prostate capsule sparing or neurovascular bundles sparing
Primary outcomes (3)
- measure
- day-time continence rate
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male patients aged 18 or older. 2. Patients those who are diagnosed with urothelial carcinoma. 3. Patients those who are without tumour in the bladder neck or urethra, and prostate cancer was ruled out by MRI and serum T-PSA\<2.5ng/ml. 4. Patients those who are capable of receiving radical cystectomy with orthotopic ileal neobladder. 5. Patients those who are able to cooperate and complete the follow-up. 6. Patients those who volunteer to participate in this study and sign the informed consens. Exclusion Criteria: 1. Patients thsoe who are diagnosed distant metastasis before surgery. 2. Patients those who are diagnosed with other malignancies. 3. Patients those who had received pelvic radiotherapy or major pelvic operation.
References
Publications (0)
Data not yet available
No reference posted for this study.